Why is target trial emulation not being used in health technology assessment real-world data submissions?

被引:0
|
作者
Castanon, Alejandra [1 ]
Duffield, Stephen [2 ]
Ramagopalan, Sreeram [1 ]
Reynolds, Robert [3 ]
机构
[1] Lane Clark & Peacock LLP, London W1U 1DQ, England
[2] Natl Inst Hlth Care Excellence, Manchester M1 4BT, Lancs, England
[3] GSK, New York, NY USA
关键词
health technology assessment; observational data; randomized controlled trials; real-world data; target trial emulation;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [22] HOW IS REAL-WORLD EVIDENCE REALLY BEING USED IN HEALTH TECHNOLOGY ASSESSMENTS - A CANADIAN CASE STUDY
    Boss, J.
    Shulak, L.
    Blaskovich, C.
    Sullivan, S.
    VALUE IN HEALTH, 2022, 25 (12) : S5 - S5
  • [23] From Trial to Target Populations - Calibrating Real-World Data
    Najafzadeh, Mehdi
    Schneeweiss, Sebastian
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (13): : 1203 - 1205
  • [24] Carfilzomib's Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health Records
    Jang, Ha Young
    Lee, Hyun Kyung
    Kim, Chae Jeong
    Yoon, Sung-Soo
    Kim, In-Wha
    Oh, Jung Mi
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (20)
  • [25] Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records
    Barbati, Giulia
    Gregorio, Caterina
    Scagnetto, Arjuna
    Indennidate, Carla
    Cappelletto, Chiara
    Di Lenarda, Andrea
    PLOS ONE, 2024, 19 (08):
  • [26] A REVIEW OF REAL-WORLD EVIDENCE IN NON-ONCOLOGY SUBMISSIONS MADE TO FOUR HEALTH TECHNOLOGY ASSESSMENT (HTA) AGENCIES
    Balijepalli, C.
    Li, J.
    Ferrazzi, S.
    Mathers, E.
    Gullapalli, L.
    Awan, A.
    VALUE IN HEALTH, 2024, 27 (06) : S253 - S254
  • [27] Integration of real-world evidence from different data sources in health technology assessment
    Graili, Pooyeh
    Guertin, Jason R.
    Chan, Kelvin K. W.
    Tadrous, Mina
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2023, 26 : 11460
  • [28] IDENTIFYING FIT-FOR-EMULATION DATA: ADAPTATION OF A STRUCTURED DATA FEASIBILITY ASSESSMENT PROCESS FOR REAL-WORLD ONCOLOGY TRIAL EMULATIONS
    Levy, N.
    Campbell, U.
    Sheridan, P.
    Lenis, D.
    Madsen, A.
    O'Doherty, I
    Estrin, A.
    Iyer, M.
    McDonald, S.
    Becnel, L.
    Belli, A.
    Carrigan, G.
    Chan, K. A.
    Chen, J.
    Chia, V. M.
    Dhopeshwarkar, N.
    Eckert, J. C.
    Fernandes, L.
    Goldstein, M.
    Greshock, J.
    Hendricks-Sturrup, R.
    Huang, J.
    Jiao, X.
    Khosla, S.
    Lunacsek, O.
    McRoy, L.
    Natanzon, Y.
    Ovbiosa, O.
    Pace, N. D.
    Pinheiro, S.
    Quinn, J.
    Rees, M.
    Rider, J.
    Rimawi, M.
    Robinson, T.
    Rodriguez-Watson, C.
    Sangli, C.
    Sarsour, K.
    Schneeweiss, S.
    Shapiro, M.
    Stewart, M.
    Taylor, A.
    Wang, C.
    Wasserman, A.
    Zhang, Y.
    VALUE IN HEALTH, 2024, 27 (12) : S597 - S597
  • [29] TARGET TRIAL EMULATION (TTE) FOR REAL WORLD DATA ANALYSES TO SUPPORT HTA DECISIONS
    Bennett, A.
    Kreif, N.
    Manca, A.
    VALUE IN HEALTH, 2022, 25 (12) : S359 - S360
  • [30] Emulation of target trials using real-world data A general principle to address the challenges of observational data
    Braitmaier, Malte
    Didelez, Vanessa
    PRAVENTION UND GESUNDHEITSFORDERUNG, 2022,